|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.42 USD | +0.20% |
|
-9.43% | +30.41% |
| Market Cap | 2.78B 2.44B 2.25B 2.07B 3.91B 268B 3.97B 26.93B 10.55B 131B 10.44B 10.21B 452B | P/E 2026 * |
-8.16x | P/E 2027 * | -8.07x |
|---|---|---|---|---|---|
| Enterprise Value | 2.2B 1.92B 1.78B 1.64B 3.09B 212B 3.14B 21.27B 8.33B 104B 8.25B 8.07B 357B | EV / Sales 2026 * |
834x | EV / Sales 2027 * | 190x |
| Free-Float |
99.73% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Celldex Therapeutics, Inc.
| 1 day | +0.20% | ||
| 1 week | -9.43% | ||
| Current month | -4.81% | ||
| 1 month | +9.22% | ||
| 3 months | +2.52% | ||
| 6 months | +38.09% | ||
| Current year | +30.41% |
| 1 week | 34.37 |  | 39.22 |
| 1 month | 32.26 | | 40.3 |
| Current year | 22.33 | | 40.3 |
| 1 year | 19.72 | | 40.3 |
| 3 years | 14.4 | | 53.18 |
| 5 years | 14.4 | | 57.2 |
| 10 years | 1.5 | | 75.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tibor Keler
CTO | Chief Tech/Sci/R&D Officer | 67 | 29/07/2014 |
Anthony Marucci
CEO | Chief Executive Officer | 64 | 31/08/2008 |
Sam Martin
DFI | Director of Finance/CFO | 55 | 31/03/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Anthony Marucci
BRD | Director/Board Member | 64 | 30/11/2008 |
Harry Penner
CHM | Chairman | 80 | 04/06/2025 |
Herbert Conrad
BRD | Director/Board Member | 93 | 29/02/2008 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/06/26 | Free | Executive/Senior Manager | 90,000 | 0.1147% | ||
| 25/06/26 | Free | General Counsel | 95,000 | 0.1210% | ||
| 25/06/26 | Free | Founder | 375,000 | 0.4778% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.20% | -9.43% | +58.05% | -4.45% | 2.77B | |
| -0.49% | -3.58% | -0.84% | +2.13% | 49.18B | |
| -3.10% | -3.47% | +370.99% | +567.62% | 39.58B | |
| -0.46% | +3.98% | +5.44% | +60.79% | 34.69B | |
| -1.14% | -1.90% | +26.94% | -9.56% | 34.42B | |
| -1.82% | -1.48% | +0.52% | +32.02% | 27.11B | |
| -3.54% | -6.91% | - | - | 16.21B | |
| -1.82% | -1.91% | +69.28% | +112.51% | 15.36B | |
| +1.17% | +3.10% | +15.87% | +16.79% | 14.05B | |
| -2.25% | -0.92% | +15.77% | -32.78% | 13.02B | |
| Average | -1.33% | -1.11% | +62.45% | +82.79% | 24.64B | |
| Weighted average by Cap. | -1.42% | -0.48% | +75.70% | +116.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.63M 2.31M 2.13M 1.96M 3.71M 254M 3.76M 25.52M 10M 124M 9.89M 9.68M 428M | 11.96M 10.48M 9.69M 8.91M 16.84M 1.15B 17.09M 116M 45.39M 564M 44.92M 43.93M 1.94B |
| Net income | -330M -289M -267M -246M -465M -31.83B -472M -3.2B -1.25B -15.57B -1.24B -1.21B -53.63B | -367M -322M -298M -274M -517M -35.44B -525M -3.56B -1.39B -17.34B -1.38B -1.35B -59.71B |
| Net Debt | -584M -512M -473M -435M -822M -56.33B -835M -5.66B -2.22B -27.56B -2.19B -2.15B -94.91B | -507M -445M -411M -378M -714M -48.93B -725M -4.91B -1.93B -23.94B -1.91B -1.86B -82.45B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | US$35.42 | +0.20% | 526,385 |
| 17/07/26 | US$35.35 | -0.14% | 1,149,060 |
| 16/07/26 | US$35.40 | -7.60% | 954,885 |
| 15/07/26 | US$38.31 | +0.37% | 534,208 |
| 14/07/26 | US$38.17 | -0.93% | 702,069 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CLDX Stock
Select your edition
All financial news and data tailored to specific country editions
